Search research articles
Contact Us
Filters
Showing results (51-60 of 384) with videos related to
Page
of 39
Sort By:
Seminars in Thrombosis and Hemostasis
|
January 1, 1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin
D D Callas, D Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis
|
January 1, 1991
Protamine sulfate neutralization of lactobionic acid amides
D Hoppensteadt, J M Walenga, J Fareed
Therapeutic Drug Monitoring
|
January 1, 1988
Pharmacokinetics of heparins differing in mean molecular weight using a Xa amidolytic and Heptest clotting method
R M Emanuele, A Racanelli, J Fareed
Seminars in Thrombosis and Hemostasis
|
October 1, 1984
Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation
J M Walenga, J Fareed, D Hoppensteadt
Seminars in Thrombosis and Hemostasis
|
October 1, 1989
In vitro protamine neutralization profiles of heparins differing in source and molecular weight
A Racanelli, D A Hoppensteadt, J Fareed
Clinical Chemistry
|
September 23, 1997
Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs
D A Hoppensteadt, S Kahn, J Fareed
Drugs & Aging
|
September 1, 1992
Low molecular weight heparins. An objective overview
D Hoppensteadt, J M Walenga, J Fareed
Thrombosis Research
|
November 1, 1990
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparin
D Hoppensteadt, J M Walenga, J Fareed
Archives of Neurology
|
September 1, 1980
Lithium carbonate therapy for cluster headache. Changes in number of platelets, and serotonin and histamine levels
J L Medina, J Fareed, S Diamond
Thrombosis Research
|
May 1, 1991
Influence of synthetic sulfated bis-lactobionic acid amides on tissue-type plasminogen activator release
H P Kloecking, A Hoffmann, J Fareed
Page
of 39
Search research articles
Search
Showing results (51-60 of 384) with videos related to
Sort By:
Page
of 39
Seminars in Thrombosis and Hemostasis
|
January 1, 1995
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin
D D Callas, D Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis
|
January 1, 1991
Protamine sulfate neutralization of lactobionic acid amides
D Hoppensteadt, J M Walenga, J Fareed
Therapeutic Drug Monitoring
|
January 1, 1988
Pharmacokinetics of heparins differing in mean molecular weight using a Xa amidolytic and Heptest clotting method
R M Emanuele, A Racanelli, J Fareed
Seminars in Thrombosis and Hemostasis
|
October 1, 1984
Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation
J M Walenga, J Fareed, D Hoppensteadt
Seminars in Thrombosis and Hemostasis
|
October 1, 1989
In vitro protamine neutralization profiles of heparins differing in source and molecular weight
A Racanelli, D A Hoppensteadt, J Fareed
Clinical Chemistry
|
September 23, 1997
Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs
D A Hoppensteadt, S Kahn, J Fareed
Drugs & Aging
|
September 1, 1992
Low molecular weight heparins. An objective overview
D Hoppensteadt, J M Walenga, J Fareed
Thrombosis Research
|
November 1, 1990
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparin
D Hoppensteadt, J M Walenga, J Fareed
Archives of Neurology
|
September 1, 1980
Lithium carbonate therapy for cluster headache. Changes in number of platelets, and serotonin and histamine levels
J L Medina, J Fareed, S Diamond
Thrombosis Research
|
May 1, 1991
Influence of synthetic sulfated bis-lactobionic acid amides on tissue-type plasminogen activator release
H P Kloecking, A Hoffmann, J Fareed
Page
of 39